CP
AMGN icon

Covenant Partners’s Amgen AMGN Stock Holding History

Covenant Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,415
Closed -$441K – 147
2025
Q1 		$441K Buy
+1,415
New +$418K 0.14% 76
2024
Q4 		– Sell
-2,007
Closed -$647K – 157
2024
Q3 		$647K Buy
2,007
+29
+1% +$9.49K 0.19% 73
2024
Q2 		$618K Sell
1,978
-17
-0.9% -$4.99K 0.19% 73
2024
Q1 		$567K Hold
1,995
– – 0.17% 89
2023
Q4 		$575K Sell
1,995
-573
-22% -$156K 0.18% 84
2023
Q3 		$690K Buy
+2,568
New +$641K 0.25% 66

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Covenant Partners's AMGN Position: Q2 2025 in Review

Covenant Partners sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,415 shares — an estimated $441K sold.

Covenant Partners first reported a position in AMGN in Q3 2023 and held it in 6 quarters. The position peaked at $690K in Q3 2023. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Covenant Partners reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Covenant Partners sold 1,415 Amgen shares in Q2 2025, an estimated $441K.
  • Covenant Partners first reported a position in Amgen in Q3 2023 and held it in 6 quarters.
  • Covenant Partners's Amgen position peaked at $690K in Q3 2023.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Covenant Partners's 13F filing for Q2 2025, filed 30 Jul 2025.